Amylyx Pharmaceuticals, Inc.
Ticker: AMLX
| Insider | Title |
|---|---|
| 96 Llc Dragsa | 10% or greater ownership |
| Bernhardt G Zeiher | Director |
| Camille L Bedrosian | Chief Medical Officer |
| Daphne Quimi | Director |
| David C. Ott | 10% or greater ownership |
| George M Jr Milne | Director |
| Gina Mazzariello | Chief Legal Officer |
| Global Investors Lp Viking | 10% or greater ownership |
| Global Opportunities Gp Llc Viking | 10% or greater ownership |
| Global Opportunities Illiquid Investments Sub-master Lp Viking | 10% or greater ownership |
| Global Opportunities Parent Gp Llc Viking | 10% or greater ownership |
| Global Opportunities Portfolio Gp Llc Viking | 10% or greater ownership |
| Invest 1 B.v. Als | 10% or greater ownership |
| Isaac Cheng | Director |
| James M Frates | Chief Financial Officer |
| Joshua B Cohen | Co-Chief Executive Officer, Director |
| Justin B. Klee | Co-Chief Executive Officer, Director |
| Karen Firestone | Director |
| Llc Mvil, | 10% or greater ownership |
| Margaret Olinger | Chief Commercial Officer |
| Ole Andreas Halvorsen | 10% or greater ownership |
| Patrick D Yeramian | Chief Medical Officer |
| Paul R. Fonteyne | Director |
| Rose Sharon Shabet | 10% or greater ownership |
| Venture Investments Ltd Morningside | 10% or greater ownership |